Gut-liver changes drive foodborne infection severity in fatty liver disease
A research team led by the University of California, Irvine’s Joe C. Wen School of Population & Public…
Man diagnosed with cancer dismissed symptoms as heartburn | Health
John Wardman was diagnosed with esophageal cancer. (John Wardman via SWNS) By Ed Chatterton A dad of one…
Molecular test shows high sensitivity in detecting bile duct cancer
When patients develop a narrowing or blockage in the bile ducts – the tubes connecting the liver, gallbladder…
The role and possible mechanism of intestinal fungi in the progression of chronic liver diseases
Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world.…
New research initiative aims to predict and prevent diseases before they start
What if doctors could tell you a disease was coming years before you felt a single symptom-and stop…
New pathway found connecting liver congestion to fibrosis and cancer
Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through…
Teva Pivot to Growth: Stepping Up Innovation
Now in its acceleration phase, Teva continues to step up innovation by working on breakthrough treatments for diseases…
Dysplasia grade predicts colorectal cancer risk in people with IBD
People with inflammatory bowel disease (IBD) and precancerous colorectal lesions are much more likely to develop colorectal cancer,…
Dietary fiber deficiency exacerbates intestinal inflammation via miR-6240-enriched gut extracellular vesicles
Magro, D. O., Sassaki, L. Y. & Chebli, J. M. F. Interaction between diet and genetics in patients…
DNA analysis of colorectal polyps improves diagnosis and treatment
In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.…
Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
Risk factors and prediction model development for pancreatic fistula following splenectomy in Wilson’s disease patients with portal hypertension | BMC Gastroenterology
Ovchinnikova EV, Garbuz MM, Ovchinnikova AA, Kumeiko VV. Epidemiology of wilson’s disease and pathogenic variants of the ATP7B…